0001613859-19-000018.txt : 20190606 0001613859-19-000018.hdr.sgml : 20190606 20190606160239 ACCESSION NUMBER: 0001613859-19-000018 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190603 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20190606 DATE AS OF CHANGE: 20190606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRA Health Sciences, Inc. CENTRAL INDEX KEY: 0001613859 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 463640387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36732 FILM NUMBER: 19882605 BUSINESS ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 9197868200 MAIL ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 8-K 1 a2019annualreport8-k.htm 8-K Document



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 3, 2019
 
PRA Health Sciences, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-36732
46-3640387
(State or Other
Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)

4130 ParkLake Avenue
Suite 400
Raleigh, NC 27612
(919) 786-8200
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
Title of each class
 
Name of exchange on which registered
 
Trading symbol
Common Stock $0.01 par value
 
Nasdaq Global Select Market
 
PRAH

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
◬    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
◬
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
◬
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
◬
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ◬
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◬


 





Item 5.07.     Submission of Matters to a Vote of Security Holders.

On June 3, 2019, PRA Health Sciences, Inc. (the “Company”) held its 2019 annual meeting of stockholders. A quorum was present at the meeting, as required by the Company’s Amended and Restated Bylaws. The immediately following charts set forth the number of votes cast for and against, and the number of abstentions and broker non-votes, with respect to each matter voted upon by the stockholders.

Proposal 1 - Election of Directors
The following two individuals were elected to the Company’s Board of Directors to serve as Class II directors until the Company’s 2022 annual meeting of stockholders and until their successors have been duly elected and qualified.

 
Votes
For
Votes Withheld
Broker
Non-Votes
Jeffrey T. Barber
59,519,751
500,342
1,398,887
Linda S. Grais, M.D.
57,001,147
3,018,946
1,398,887

Proposal 2 - Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for 2019
The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019 was ratified.

Votes
For
Votes Against
Votes Abstained
61,219,643
95,172
104,165

Proposal 3 - Non-Binding Vote on Executive Compensation
The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company’s named executive officers.

Votes
For
Votes Against
Votes Abstained
Broker
Non-Votes
56,944,395
3,006,941
68,757
1,398,887





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
PRA Health Sciences, Inc.
 
 
 
 
 
Date: June 6, 2019
 
 
 
 
 
 
By:
 
/s/ Michael J. Bonello
 
 
Name:
 
Michael J. Bonello
 
 
Title:
 
Executive Vice President, Chief Financial Officer and Secretary